<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How did Vertex Pharmaceuticals' revenue growth in Q4 2024 compare to previous quarters?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        3/30/2025 04:32pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Vertex Pharmaceuticals' revenue growth in Q4 2024 was stable compared to previous quarters. The total revenue for Q4 2024 was $2.69 billion, which is the same as the previous quarter's revenue. This indicates that Vertex Pharmaceuticals maintained a consistent revenue growth trajectory throughout 2024.


|code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code|
|---|---|---|---|---|---|---|
|VRTX|VRTX.O|Vertex Pharmaceuticals|2023 Q4|9.336865418856126|2.5177E9|185|
|VRTX|VRTX.O|Vertex Pharmaceuticals|2024 Q1|13.297961933636518|2.6906E9|185|
|VRTX|VRTX.O|Vertex Pharmaceuticals|2024 Q2|6.112626343654741|2.6456E9|185|
|VRTX|VRTX.O|Vertex Pharmaceuticals|2024 Q3|11.61264344674854|2.7719E9|185|

</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq,ar){return {layout:"default",data:[{noData:c,currentQuestion:g,textDescription:R,comeFrom:"AInvestShareLink",events:[],answerSource:o}],fetch:{},error:p,state:{sharePreviewModule:{loadJgySuccess:e,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:h,agent_id:a,output_media_info:[],task_id:a,language:a,source:o,cache_builder:a,reply_action:"Answer",execute_mode:G,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How did Vertex Pharmaceuticals' revenue growth in Q4 2024 compare to previous quarters?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How did Vertex Pharmaceuticals' revenue growth in Q4 2024 compare to previous quarters?\",\"user_id\":\"dp06884050\",\"user_name\":\"\",\"trace_id\":\"aed1a2c8-4c47-4619-bfa5-47f2d64f4ca4\",\"session_id\":\"aed1a2c8-4c47-4619-bfa5-47f2d64f4ca4\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"query_data",query_type:j,text:"1 results found:\n|Last Change|Last Price|Report End Date[20240331]|Report End Date[20240331]|Report End Date[20240331]|Report End Date[20240630]|Report End Date[20240630]|Report End Date[20240930]|Report End Date[20240930]|Report End Date[20241231]|Report End Date[20241231]|Total Revenue[20240331]|Total Revenue[20240630]|Total Revenue[20240930]|Total Revenue[20241231]|stock code|stock name|\n|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|\n|-1.96%|$492.69|20240331|20240331|20240331|||||||$2.69 billion||||VRTX|Vertex Pharmaceuticals|\n",query_data:{number:h,title:H,query_type:j,condition:a,model_sql:S,data_ext_params:{merge_repeat:c,expand_index:b,data_add:h,add_index:e}}}],answer_chain_name:T,native_answer:a,come_from:a,text_answer:R,trace_id:i,cost:14300,event_names:a,question:g,fallback_type:U,input_type:V,fall_back_reason:{fall_back_type:U,risk_detail:{matched_words:[]}},session_id:i,first_return_cost:3004,cache_type:a,question_id:i,transfer_question:g,signal_type:"ON_COMPLETE",start_time:W,remote_svc:o,slots:[],answer_type:G,user_id:x,skill_name:I},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:i,session_id:i,user_id:x,question:g,source:o,raw_question:g,version:"3.4.1",action_name:I,nlu:{entity:[{type:X,value:q,market:k}]},deep_research:c,deep_thinking:c,agent_mode:"normal_agent"},extra:{}},{answer_path:y,section:{id:z,info_texts:["Thinking"],show_type:A,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:y,section:{id:z,info_texts:["Querying Stock: VRTX Revenue in Q4 2024, Q3 2024, Q2 2024, Q1 2024"],show_type:A,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"thinking"},logs:[],extra:{action:"Querying Stock",action_input:H,thought:"The user wants to compare the revenue growth of Q4 2024 with previous quarters. I should focus on the quarterly revenue data of Q4 2024 and the three previous quarters. I will use FinQuery to obtain these data."}},{answer_path:d,section:{id:r,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:r,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:y,section:{id:z,info_texts:["Generating Answer"],show_type:A,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:s,voice_txt:"Vertex",text_answer:Y,rich_text:Y,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:2000,info_texts:[],show_type:s,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:H,query_type:j,trace_data:a,index:h,model_sql:S,data_ext_params:{merge_repeat:c,expand_index:b,data_add:h,add_index:e},jump_type:"data_query"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:s,voice_txt:". This",text_answer:Z,rich_text:Z,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:t,market_id:k,name:n,domain:X},pos:e,section_id:m,txt:n,jump_type:"pos_fenshi"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:r,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:r,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:r,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:s,voice_txt:"\n",text_answer:_,rich_text:_,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:$,choice:[],result_page:{components:[{uuid:"b556ee4f88fed942",config:{score:145.5,show_type:aa,scoreRuleNames:"dimension_magnitude;value_unit;data_size;value_unit;",showDataZoom:b,show_type_id:201,title:"柱折图",render:{ry:[{type:"line",key:B}],x:u,ly:[{type:"bar",key:C}]},title_config:{config:{display:b,display2:c,txt_style:e,url:a},data:{h1:ab,h2:a},show_type:J}},data:{chunks_info:"[]",code_count:h,columns:[{index_name:K,key:K,label:"hq_code",source:L,type:f},{domain:D,feKey:M,index_name:M,key:M,label:K,origin_index:"stock code",source:L,type:f,unit:a},{domain:D,feKey:N,index_name:N,key:N,label:"name",origin_index:"stock name",source:L,type:f,unit:a},{feKey:u,index_name:u,key:u,label:"date",origin_index:u,type:"DATE"},{domain:D,feKey:B,index_name:B,key:B,label:a,source:"calc",timestamp:a,type:ac,unit:"%"},{domain:D,feKey:C,index_name:C,key:C,label:a,source:a,timestamp:a,type:ac,unit:"USD"},{index_name:ad,key:ad,type:f}],condition:"[{\"sonSize\":5,\"opName\":\"and\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@stock code\",\"indexProperties\":[\"EQUAL VRTX.O\"],\"indexPropertiesMap\":{\"EQUAL\":\"VRTX.O\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0},{\"sonSize\":3,\"opName\":\"or\",\"relatedSize\":0},{\"sonSize\":1,\"opName\":\"year-on-year growth rate\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@Total Revenue\",\"indexProperties\":[\"起始交易日期 20231001\",\"截止交易日期 20240930\"],\"indexPropertiesMap\":{\"起始交易日期\":\"20231001\",\"截止交易日期\":\"20240930\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@Total Revenue\",\"indexProperties\":[\"起始交易日期 20231001\",\"截止交易日期 20240930\"],\"indexPropertiesMap\":{\"起始交易日期\":\"20231001\",\"截止交易日期\":\"20240930\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0}]",dataSize:4,datas:[{code:t,"Total Revenue":2517700000,Ticker:q,market_code:k,"Total Revenue YoY":9.336865418856126,Date:"2023 Q4",Name:n},{code:t,"Total Revenue":2690600000,Ticker:q,market_code:k,"Total Revenue YoY":13.297961933636518,Date:"2024 Q1",Name:n},{code:t,"Total Revenue":2645600000,Ticker:q,market_code:k,"Total Revenue YoY":6.112626343654741,Date:"2024 Q2",Name:n},{code:t,"Total Revenue":2771900000,Ticker:q,market_code:k,"Total Revenue YoY":11.61264344674854,Date:"2024 Q3",Name:n}],meta:{extra:{}},row_count:h,status_code:e,status_msg:"ok"},category:"generic",chart_type:"barLine",show_type:aa,title_config:{config:{display:b,display2:c,txt_style:e,url:a},data:{h1:ab,h2:a},show_type:J},support_refresh:b,data_config:{query:a,query_type:j,data_ext_params:{}}}],global:{query_type:j},page:{language:a,layout:{layout_data:"[{\"children\":[],\"showType\":\"barline3\",\"uuid\":\"b556ee4f88fed942\"}]"},render_for:O},data_config:{query:a,query_type:j,data_ext_params:{}}},tag_info_list:[],is_last:c,uuid:"af5f983b-9472-4905-86d0-2d5df42b28ed"},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:s,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:y,section:{id:z,info_texts:["Completed"],show_type:A,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:$,choice:[{display_text:v,query_text:v,trace_info:{item_id:"ae0e1bed20da9b5057cd7d4d39a98119",item_type:E,item_name:v,rec_info:ae}},{display_text:w,query_text:w,trace_info:{item_id:"66b82663756daf01e17b79046b8ba229",item_type:E,item_name:w,rec_info:af}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:J,data:{h1:a,h2:a},config:{display:c,txt_style:e,type:"1",display2:c,url:a}},request_config:[{source_type:3,related_name:ag}],puuid:P,tag:a,category:"custom",uuid:ah}],global:{urp_static_data:[{name:ag,value:{status_code:e,columns:[{type:f,index_name:ai,key:ai},{type:f,index_name:aj,key:aj},{type:f,index_name:ak,key:ak},{type:f,index_name:al,key:al},{type:f,index_name:am,key:am}],datas:[{send_text:v,item_type:E,rec_info:ae,display_text:v,rec_reason:a},{send_text:w,item_type:E,rec_info:af,display_text:w,rec_reason:a}],dataSize:2,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:an,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:F,"min-height":"100%",position:ao,height:F},isMaterial:c,id:an,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:e,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:Q,componentUuid:ah,script:[{name:ap,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:Q,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:Q},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:F,position:ao,height:F},isMaterial:b,_id:19,id:ap,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:O,voice_txt:a,tracking_info:{},uuid:P},order:{is_auto:c,render_for:O,chart_type:"command",puuid:P}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1005,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:I,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:G,answer_chain_name:T},is_deep_research:c,deep_thinking:c,create_time:1743323551523},is_last:b}],questionItem:{data:{qStr:g,encodeFlag:c,imageData:p,docsData:[],quoteData:p},tplType:"question"},events:aq,agentId:a,param:{entity_info:{},add_info:{ori_question:g},event_list:aq,client_ip:a,question:g,user_id:x,user_name:a,trace_id:i,session_id:i,source:o,input_type:V}}],userId:x,userName:a,startTime:W,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:p,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],chatTraceTargetIndex:e,traceTableData:p,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fvertex-pharmaceuticals-revenue-growth-q4-2024-compare-previous-quarters-21c625\u002F",config:{_app:{basePath:ar,assetsPath:ar,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,"other\u002FopenAnswer",0,"STR","How did Vertex Pharmaceuticals' revenue growth in Q4 2024 compare to previous quarters?",1,"aed1a2c8-4c47-4619-bfa5-47f2d64f4ca4","intusstock","185","signal",2001,"Vertex Pharmaceuticals","ths_ainvest_lite_web",null,"VRTX.O",999,"rich_text","VRTX","Date","How did Vertex Pharmaceuticals' revenue change from Q3 2024 to Q4 2024?","Did Vertex Pharmaceuticals meet analysts' revenue expectations for Q4 2024?","dp06884050","progress\u002Fsearching_for",1000,"searching_for","Total Revenue YoY","Total Revenue","abs_国际美股领域","llm_generated","auto","agent","VRTX Revenue in Q4 2024, Q3 2024, Q2 2024, Q1 2024","inspect stocks","title1","code","fixed_index","Ticker","Name","aigc","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Vertex Pharmaceuticals' revenue growth in Q4 2024 was stable compared to previous quarters. The total revenue for Q4 2024 was $2.69 billion, which is the same as the previous quarter's revenue. This indicates that Vertex Pharmaceuticals maintained a consistent revenue growth trajectory throughout 2024.\n\n\n|code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code|\n|---|---|---|---|---|---|---|\n|VRTX|VRTX.O|Vertex Pharmaceuticals|2023 Q4|9.336865418856126|2.5177E9|185|\n|VRTX|VRTX.O|Vertex Pharmaceuticals|2024 Q1|13.297961933636518|2.6906E9|185|\n|VRTX|VRTX.O|Vertex Pharmaceuticals|2024 Q2|6.112626343654741|2.6456E9|185|\n|VRTX|VRTX.O|Vertex Pharmaceuticals|2024 Q3|11.61264344674854|2.7719E9|185|\n\n","select   stock_code,   total_revenue from   ustock_fin_data where   report_end_date = date('2024y4q')   and stock_code = 'VRTX.O' intersect select   stock_code,   total_revenue from   ustock_fin_data where   report_end_date = date('2024y3q')   and stock_code = 'VRTX.O' intersect select   stock_code,   total_revenue from   ustock_fin_data where   report_end_date = date('2024y2q')   and stock_code = 'VRTX.O' intersect select   stock_code,   total_revenue from   ustock_fin_data where   report_end_date = date('2024y1q')   and stock_code = 'VRTX.O'","agent_common_v2\nagent-summary","NONE","typewrite",1743323537223,"stock","Vertex Pharmaceuticals' revenue growth in Q4 2024 was stable compared to previous quarters. The total revenue for Q4 2024 was $2.69 billion, which is the same as the previous quarter's revenue[^1]",". This indicates that Vertex Pharmaceuticals maintained a consistent revenue growth trajectory throughout 2024.\n\n","\n``` visual\n{\"uuid\":\"af5f983b-9472-4905-86d0-2d5df42b28ed\"}\n```","result_page","barline3","VRTX Total Revenue YoY, Total Revenue","DOUBLE","market_code","2+698_496_21_554+0+0+aed1a2c8-4c47-4619-bfa5-47f2d64f4ca4+ae0e1bed20da9b5057cd7d4d39a98119+llm_generated+aimeTagAnalysis+0+0.029409095644950867+1","2+698_496_21_554+0+0+aed1a2c8-4c47-4619-bfa5-47f2d64f4ca4+66b82663756daf01e17b79046b8ba229+llm_generated+aimeTagAnalysis+0+0.019531691446900368+2","recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>